Several recent studies describing a solely vascular presentation of cystathionine beta-synthase (CBS) deficiency in adulthood prompted us to analyze the frequency of patients manifesting with vascular complications in the Czech Republic. Between 1980 and 2009, a total of 20 Czech patients with CBS deficiency have been diagnosed yielding an incidence of 1:311,000. These patients were divided into three groups based on symptoms leading to diagnosis: those with vascular complications, with connective tissue manifestation and with neurological presentation. A vascular event such as a clinical feature leading to diagnosis of homocystinuria was present in five patients, while two of them had no other symptoms typical for CBS deficiency at the time of diagnosis. All patients with the vascular manifestation were diagnosed only during the past decade. The median age of diagnosis was 29 years in the vascular, 11.5 years in the connective tissue and 4.5 years in the neurological group. The ratio of pyridoxine responsive to nonresponsive patients was higher in the vascular (4 of 5 patients) and connective tissue groups (6 of 7 patients) than in the neurological group (2 of 8 patients). Mutation c.833T>C (p.I278T) was frequent in patients with vascular (6/10 alleles) and connective tissue presentation (8/14 alleles), while it was not present in patients with neurological involvement (0/16 alleles). During the last decade, we have observed patients with homocystinuria diagnosed solely due to vascular events; this milder form of homocystinuria usually manifests at greater ages, has a high ratio of pyridoxine responsiveness/nonresponsiveness, and the mutation c.833T>C (p.I278T) is often present.

Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University Prague Praha Czech Republic

Zobrazit více v PubMed

Araki A, Sako Y. Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr. 1987;422:43–52. doi: 10.1016/0378-4347(87)80438-3. PubMed DOI

Brattström L, Israelsson B, Lindgärde F, Hultberg B. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism. 1988;37:179–184. doi: 10.1016/S0026-0495(98)90014-2. PubMed DOI

Gaustadnes M, Rudiger N, Rasmussen K, Ingerslev J. Familial thrombophilia associated with homozygosity for the cystathionine beta-synthase 833T–>C mutation. Arterioscler Thromb Vasc Biol. 2000;20:1392–1395. PubMed

Gerritsen T, Vaughn JG, Waisman HA. The identification of homocystine in the urine. Biochem Biophys Res Commun. 1962;9:493–496. doi: 10.1016/0006-291X(62)90114-6. PubMed DOI

Janošík M, Oliveriusová J, Janošíková B, et al. Impaired heme binding and aggregation of mutant cystathionine β-synthase subunits in homocystinuria. Am J Hum Genet. 2001;68:1506–1513. doi: 10.1086/320597. PubMed DOI PMC

Janošík M, Sokolová J, Janošíková B, et al. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr. 2009;154(3):431–437. doi: 10.1016/j.jpeds.2008.09.015. PubMed DOI PMC

Kraus JP. Cystathionine beta-synthetase (human) Methods Enzymol. 1987;143:388–394. doi: 10.1016/0076-6879(87)43068-1. PubMed DOI

Krijt J, Vacková M, Kozich V. Measurement of homocysteine and other aminothiols in plasma: advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem. 2001;47:1821–1828. PubMed

Linnebank M, Junker R, Nabavi DG, Linnebank A, Koch HG. Isolated thrombosis due to the cystathionine beta-synthase mutation c.833T>C (1278T) J Inherit Metab Dis. 2003;26:509–511. doi: 10.1023/A:1025129528777. PubMed DOI

Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science. 1964;143:1443–1445. doi: 10.1126/science.143.3613.1443. PubMed DOI

Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1–31. PubMed PMC

Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. 8. New York: McGraw-Hill; 2001. pp. 2007–2056.

Orendáč M, Kožich V, Zeman J, et al. Klinický obraz homocystinurie z deficitu cystathionin β-syntázy u devatenácti českých a slovenských pacientů. Cas Lék Cesk. 2000;16:500–507. PubMed

Skovby F, Gaustadnes M, Mudd SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab. 2010;99:1–3. doi: 10.1016/j.ymgme.2009.09.009. PubMed DOI PMC

Sokolová J, Janosíková B, Terwilliger JD, Freiberger T, Kraus JP, Kozich V. Cystathionine beta-synthase deficiency in Central Europe: discrepancy between biochemical and molecular genetic screening for homocystinuric alleles. Hum Mutat. 2001;18:548–549. doi: 10.1002/humu.1239. PubMed DOI

Cystathionine β-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis

A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase

Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency

Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines